Search Grant Opportunities

Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)

ID: RFA-CA-21-014 • Type: Posted
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Sign in to upload a capability statement or catalogue for your company

Some suggestions:
Please summarize the work to be completed under this opportunity
Who is eligible to apply for this grant?
I'd like to anonymously submit a question to the procurement officer(s)
Loading

Description

The goal of this FOA is to advance cancer model systems that recapitulate human immunity in the tumor microenvironment to improve the predictivity of immuno-oncology studies. Proposed research projects must focus on recapitulation of the human immune system in their proposed cancer model using human cells or tissues to regenerate and/or recapitulate the human immune system in in vivo or in vitro immuno-oncology models in a manner that matches or exceeds representation of the human immune system achieved with murine models developed using HFT. Models derived from genetically manipulated immune systems without introduction of human immune lineage cells will not be considered responsive. The FOA will utilize the R33 Exploratory/Developmental Grants Phase II research activity code.

Overview

Category of Funding
Education
Health
Funding Instruments
Cooperative Agreement
Grant Category
Discretionary
Cost Sharing / Matching Requirement
False
Source
On 12/2/20 the National Institutes of Health posted grant opportunity RFA-CA-21-014 for Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional) with funding of $2.3 million. The grant will be issued under grant program 93.393 Cancer Cause and Prevention Research.

Timing

Posted Date
Dec. 2, 2020, 12:00 a.m. EST
Closing Date
Nov. 17, 2021, 12:00 a.m. EST Past Due
Last Updated
Dec. 2, 2020, 3:57 p.m. EST
Version
1
Archive Date
Dec. 23, 2021

Eligibility

Eligible Applicants
Independent school districts
Native American tribal governments (Federally recognized)
Public and State controlled institutions of higher education
State governments
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Special district governments
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
City or township governments
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
For profit organizations other than small businesses
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
County governments
Small businesses
Additional Info
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Award Sizing

Ceiling
$300,000
Floor
Not Listed
Estimated Program Funding
$2,250,000
Estimated Number of Grants
Not Listed

Contacts

Contact
National Institutes of Health
Contact Email
Email Description
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Contact Phone
(301) 402-2541

Documents

Posted documents for RFA-CA-21-014

Grant Awards

Grants awarded through RFA-CA-21-014

Incumbent or Similar Grants

Similar Active Opportunities

Open grant opportunities similar to RFA-CA-21-014

Experts for Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)

Recommended subject matter experts available for hire